PMC:7376974 / 82425-82867 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T387","span":{"begin":246,"end":259},"obj":"Body_part"},{"id":"T388","span":{"begin":280,"end":288},"obj":"Body_part"},{"id":"T389","span":{"begin":302,"end":306},"obj":"Body_part"}],"attributes":[{"id":"A387","pred":"fma_id","subj":"T387","obj":"http://purl.org/sig/ont/fma/fma9825"},{"id":"A388","pred":"fma_id","subj":"T388","obj":"http://purl.org/sig/ont/fma/fma84050"},{"id":"A389","pred":"fma_id","subj":"T389","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":246,"end":259},"obj":"Body_part"},{"id":"T26","span":{"begin":302,"end":306},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1481","span":{"begin":327,"end":330},"obj":"Chemical"},{"id":"1486","span":{"begin":64,"end":73},"obj":"Disease"},{"id":"1487","span":{"begin":185,"end":194},"obj":"Disease"},{"id":"1488","span":{"begin":302,"end":319},"obj":"Disease"},{"id":"1489","span":{"begin":369,"end":378},"obj":"Disease"}],"attributes":[{"id":"A1481","pred":"tao:has_database_id","subj":"1481","obj":"MESH:D017382"},{"id":"A1486","pred":"tao:has_database_id","subj":"1486","obj":"MESH:D007239"},{"id":"A1487","pred":"tao:has_database_id","subj":"1487","obj":"MESH:D007239"},{"id":"A1488","pred":"tao:has_database_id","subj":"1488","obj":"MESH:D011014"},{"id":"A1489","pred":"tao:has_database_id","subj":"1489","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T227","span":{"begin":64,"end":73},"obj":"Disease"},{"id":"T228","span":{"begin":185,"end":194},"obj":"Disease"},{"id":"T229","span":{"begin":307,"end":319},"obj":"Disease"},{"id":"T230","span":{"begin":369,"end":378},"obj":"Disease"},{"id":"T231","span":{"begin":429,"end":433},"obj":"Disease"}],"attributes":[{"id":"A227","pred":"mondo_id","subj":"T227","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A228","pred":"mondo_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A229","pred":"mondo_id","subj":"T229","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A230","pred":"mondo_id","subj":"T230","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A231","pred":"mondo_id","subj":"T231","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T759","span":{"begin":125,"end":130},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T760","span":{"begin":246,"end":259},"obj":"http://purl.obolibrary.org/obo/UBERON_0002405"},{"id":"T761","span":{"begin":302,"end":306},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T762","span":{"begin":302,"end":306},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T763","span":{"begin":386,"end":387},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T764","span":{"begin":434,"end":441},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T418","span":{"begin":327,"end":330},"obj":"Chemical"}],"attributes":[{"id":"A99457","pred":"chebi_id","subj":"T418","obj":"http://purl.obolibrary.org/obo/CHEBI_26523"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T194","span":{"begin":307,"end":319},"obj":"http://purl.obolibrary.org/obo/GO_0006954"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"LitCovid-sentences","denotations":[{"id":"T508","span":{"begin":0,"end":442},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}

{"project":"2_test","denotations":[{"id":"32667191-32402576-153385","span":{"begin":195,"end":198},"obj":"32402576"}],"text":"In particular, most of the studies showed the ability to reduce infection when HNMs were first incubated with the pathogenic virus, thus limiting their potential use in the early stage infection.124 The formulation of HNMs able to both alert the immune system (e.g., upregulating cytokine) and control lung inflammation (e.g., ROS scavenger) even after the early stage infection may be a possible strategy for treatments against SARS viruses."}